Seelos Therapeutics Announces Issuance of Composition of Matter Patent in Japan for SLS-007 Psychedelics Investing
Universal Ibogaine Announces Expansion of Executive Team andGrant of Stock Options Pharmaceutical Investing
NeonMind to Present at H.C. Wainwright 2nd Annual Psychedelics Virtual Conference Psychedelics Investing
COMPASS Pathways announces further positive results from groundbreaking phase IIb trial of investigational COMP360 psilocybin therapy for treatment-resistant depression Psychedelics Investing
Love Pharma's Acquisition Will Offer Exclusive Partnership and License with World Renowned University to Conduct Landmark Psilocybin Study Pharmaceutical Investing
Numinus to Participate in the H.C. Wainwright 2nd Annual Psychedelics Virtual Conference on December 6th Pharmaceutical Investing
COMPASS Pathways to participate in upcoming Evercore, H.C. Wainwright & Berenberg investor conferences Psychedelics Investing
